ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $72,000 | +100.0% | 11,893 | +17.5% | 0.00% | +50.0% |
| Q3 2019 | $36,000 | +33.3% | 10,118 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $27,000 | -10.0% | 10,118 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $30,000 | +87.5% | 10,118 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $16,000 | -56.8% | 10,118 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $37,000 | +27.6% | 10,118 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $29,000 | -23.7% | 10,118 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $38,000 | +31.0% | 10,118 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $29,000 | -43.1% | 10,118 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $51,000 | +10.9% | 10,118 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $46,000 | +7.0% | 10,118 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $43,000 | +2.4% | 10,118 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $42,000 | -48.8% | 10,118 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $82,000 | -17.2% | 10,118 | +0.6% | 0.00% | -33.3% |
| Q1 2015 | $99,000 | – | 10,054 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |